Neurology
Conference Coverage
Long-term metformin use protective against neurodegenerative disease
Use of metformin for at least 2 years had a protective effect on the incidence of neurodegenerative disease among elderly veterans, according to...
Conference Coverage
Sleep apnea in later life more than doubles subsequent Alzheimer’s risk
DENVER – Cognitively intact patients when diagnosed with obstructive sleep apnea after age 65 were 2.2-fold more likely than were controls to...
Conference Coverage
Insomnia is pervasive in adult neurodevelopmental disorders
DENVER – Look for clinically significant sleep disturbances in adults with ADHD or autism spectrum disorder.
Conference Coverage
Updated Behçet’s disease recommendations expand biologic treatment
Conference Coverage
SLEEP TIGHT: CPAP may be vasculoprotective in stroke/TIA
DENVER – Continuous positive airway pressure treatment of obstructive sleep apnea in patients with a recent TIA or mild stroke appears to reduce...
Conference Coverage
Real-world MS relapse rate is low for dimethyl fumarate
Key clinical point: Comparison of five disease-modifying therapies for MS has revealed the lowest relapse rate for dimethyl fumarate, which should...
Conference Coverage
Alemtuzumab beneficial for MS patients of African descent
Key clinical point: Alemtuzumab had clinical and radiologic benefits in patients of African descent with active RRMS. Major finding: No evidence...
Conference Coverage
Exercise improves sleep and may improve cognitive/physical function in MS
Moderate-intensity exercise may benefit MS patients in terms of improved sleep and perhaps improved cognitive and physical function.
Conference Coverage
Edaravone slows progression of ALS when started early on
Key clinical point: When added to standard of care, edaravone slows loss of function in patients with early-stage ALS. Major finding: Compared...
Conference Coverage
Real-world data favor dimethyl fumarate, fingolimod for MS
Key clinical point: In real-world care, dimethyl fumarate and fingolimod appear more effective than other disease-modifying therapies for MS....
Conference Coverage
Oral contraceptive efficacy unaffected by dimethyl fumarate
Key clinical point: Delayed-release dimethyl fumarate can be used in childbearing women with RRMS without fear of compromising the effect of a...